Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Uniwersytecki Szpital Kliniczny W Opolu, Opole, Poland
Brigham and Women's Hospital, Boston, Massachusetts, United States
The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
Phoenix Clinical Research, Tamarac, Florida, United States
Chesapeake Research Group, Llc, Pasadena, Maryland, United States
The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
Zhejiang Cancer Hospital, Hanzhou, China
Zhejiang Cancer Hospital, Hanzhou, China
Seok Kyeong Oh, Seoul, Gangnam-gu, Korea, Republic of
Cardiosurgery departments with intensive care block, Kyiv, Ukraine
Anesthesia department Medical Network Dobrobut, Kyiv, Ukraine
Medical Network Dobrobut, Kyiv, Ukraine
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.